IL1RAPL1 and neoplasm: However, it remains unclear whether the clinical effects (both toxicity and anti-tumour activity) of MRX34 are related to specific gene-suppressing activity of the miR-34a nucleotide, a non-specific inflammatory effect of the double-stranded RNA (dsRNA) of the MRX34 formulation,42–44 or some other mechanism.